The use of neuropeptides (memoprove™) in geriatric pharmacology

  • Svitlana Kuznetsova D. F. Chebotarev Institute of Gerontology NAMS of Ukraine
  • Viktor Kuznetsov D. F. Chebotarev Institute of Gerontology NAMS of Ukraine
Keywords: MemoProve™; elderly; emotional-mnestic parameters; brain bioelectrical activity; cerebral haemodynamics

Abstract

The article presents our own data on the effect of the MemoProve™ course of treatment (1 tablet for 30 days) in 20 elderly researchers (mean age 68.2+3.2 years) on mnestic processes (short-term, long-term memory), emotional background (anxiety level); besides, the article presents a structural characteristic of the reorganisation of the brain bioelectrical activity and changes in cerebral haemodynamics. Three types of EEG response to MemoProve™ have been identified. Common to these types is an increase in the total power of brain electrogenesis (by 15-25%) and an increase in the frequency of the arhythm, the main, basic EEG rhythm. The type of influence of MemoProve™ on the power of slow rhythms (delta, theta) depends on the EEG type.

In elderly patients, MemoProve™ caused an increase in the Linear Systolic Blood Flow (LSBF) rate in the two middle cerebral arteries (MCAs), vertebral arteries (VAs) and basilar artery (BA). The results of a comprehensive analysis of the impact of the MemoProve™ course of treatment testify to its positive effect on the brain functional state (according to emotional-mnestic parameters, brain bioelectrical activity, cerebral haemodynamics) in the elderly and give reason to recommend MemoProve™ for use in the geriatric pharmacological correction of emotional-mnestic activity.

Author Biographies

Svitlana Kuznetsova, D. F. Chebotarev Institute of Gerontology NAMS of Ukraine

DSc  (Medicine), Prof., Corresp. Member of NAMS of Ukraine, Head of Department of Vascular Pathology of the Brain

Viktor Kuznetsov, D. F. Chebotarev Institute of Gerontology NAMS of Ukraine

DSc  (Medicine), Leading Researcher of Department of Vascular Pathology of the Brain, Department of Rehabilitation of Neurological Patients

References

Frolkis, V. V. Ageing of Brain. Nauka: Leningrad, 1991, p. 227. (in Russian)

Ageing: Facts and Theories. Interdisciplinary Topics in Gerontology, Vol. 3, Ed.: Robert, L. (Paris); Fulop, T. (Sherbrooke, Que.), Karger: 2014, p. 215.

Kuznetsov, V. V.; Bulchak, V. N.; Kuznetsova, S. Hemispheric Peculiarities of Cerebrolysin Effects on the Brain Functional State in Patients with Atherothrombotic Ischemic Stroke. SM Gerontol Geriatr Res 2017, 1, 1, 1004, p. 1004-1007. https://doi.org/10.36876/smggr.1004

Crook, Th. H.; Ferris, St. H.; Alvarez, X. A.; Laredo, M.; Moessler, H. Effects of N-PEP-12 on memory among older adults. Int Clin Psychopharmacol 2005, 20, 2, pp. 97-100. https://doi.org/10.1097/00004850-200503000-00006

Balea, M.; Birle, C.; Costin, C. et al. Effects of N-Pep-12 dietary supplementation on neurorecovery after ischemic stroke. Neurol Sci 2021, 42, 5, 2031–2037. https://doi.org/10.1007/s10072-020-04707-9

Mijajlović, M. D.; Pavlović, A.; Brainin, M. et al. Post-stroke dementia – a comprehensive review. BMC Med 2017, 15, 1, p. 11.

Published
2022-12-06
How to Cite
Kuznetsova, S., & Kuznetsov, V. (2022). The use of neuropeptides (memoprove™) in geriatric pharmacology. Ageing and Longevity, 3(4), 135-144. Retrieved from http://aging-longevity.org.ua/index.php/journal-description/article/view/84
Section
Статьи

Most read articles by the same author(s)